Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier

被引：1
|
作者：
Payne, Aimee S. [1 ]
Vieira, Silvio Manfredo [2 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA
[2] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
10.1016/j.jid.2024.03.014
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1667 / 1670
页数：4
相关论文
共 50 条
  • [41] Pharmacological Inhibition of Bruton's Tyrosine Kinase Attenuates Experimental Abdominal Aortic Aneurysms
    Xu, Baohui
    Li, Yankui
    Li, Gang
    Ge, Yingbin
    Guo, Jia
    Fang, Weirong
    Wang, Wei
    Shen, Fanru
    Shoji, Takahiro
    Ikezoe, Toru
    Zheng, Xiaoya
    Zhao, Sihai
    Chen, Xiaofeng
    Miyata, Masaaki
    Daugherty, Alan
    Lu, Hong
    Dalman, Ronald L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [42] Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein
    Weimin Liu
    Ileana Quinto
    Xueni Chen
    Camillo Palmieri
    Ronald L. Rabin
    Owen M. Schwartz
    David L Nelson
    Giuseppe Scala
    Nature Immunology, 2001, 2 : 939 - 946
  • [43] Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective
    Ghane, Yekta
    Heidari, Nazila
    Heidari, Amirhossein
    Sadeghi, Sara
    Goodarzi, Azadeh
    HELIYON, 2023, 9 (12)
  • [44] Open trial of Bruton's tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus
    Goodale, Elizabeth C.
    White, Stephen D.
    Bizikova, Petra
    Borjesson, Dori
    Murrell, Dedee F.
    Bisconte, Angelina
    Francesco, Michelle
    Hill, Ronald J.
    Masjedizadeh, Mohammad
    Nunn, Philip
    Gourlay, Steven G.
    Jordan, Tyler J. M.
    Emery, Carolyn B.
    Outerbridge, Catherine A.
    VETERINARY DERMATOLOGY, 2020, 31 (05) : 410 - +
  • [45] Decoding bruton's tyrosine kinase signalling in neuroinflammation
    Gruber, R.
    Dufault, M.
    Chretien, N.
    Proto, J.
    Zhang, M.
    Lamorte, M.
    Havari, E.
    Turner, T.
    Chomyk, A.
    Christie, E.
    Trapp, B.
    Ofengeim, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 270 - 270
  • [46] Bruton's tyrosine kinase in systemic lupus erythematosus
    Liao, Hsien-Tzung
    Tung, Hsiang-Yuen
    Tsai, Chang-Youh
    Chiang, Bor-Luen
    Yu, Chia-Li
    JOINT BONE SPINE, 2020, 87 (06) : 670 - 672
  • [47] Clinical potential of targeting Bruton's tyrosine kinase
    Uckun, Fatih M.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2008, 27 (1-2) : 43 - 69
  • [48] Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors
    Vincent Sibaud
    Marie Beylot-Barry
    Caroline Protin
    Emmanuelle Vigarios
    Christian Recher
    Loic Ysebaert
    American Journal of Clinical Dermatology, 2020, 21 : 799 - 812
  • [49] Role of Bruton's tyrosine kinase in macrophage apoptosis
    Khare, Anupriya
    Viswanathan, Bharathi
    Gund, Rupali
    Jain, Nidhi
    Ravindran, Balachandran
    George, Anna
    Rath, Satyajit
    Bal, Vineeta
    APOPTOSIS, 2011, 16 (04) : 334 - 346
  • [50] Bruton's Tyrosine Kinase and Its Isoforms in Cancer
    Wang, Xianhui
    Kokabee, Leila
    Kokabee, Mostafa
    Conklin, Douglas S.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
12345